ACB News & Events

Markets are looking to rebound this morning after two sessions of selling pressure, with futures higher across the major indexes. The catalyst is a combination of bargain-hunting in beaten-down technology shares. Nasdaq futures are leading the advance, reflecting renewed interest in AI and semiconductor names after a sharp pullback earlier this week.Wednesday's CPI report showed headline inflation accelerating to 4.2% year-over-year, driven largely by energy costs. Meanwhile, this morning's PPI report showed producer prices for final demand in the U.S. increased 1.1% month-over-month in May, the same as a downwardly revised 1.1% rise in April and once again above forecasts of 0.7%.In pre-market trading, S&P 500 futures rose 0.49%, Nasdaq futures rose 0.83% and Dow futures rose 0.54%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Intelup 4% after BofA double upgraded the stock to Buy from Underperform with a price target of $135, up from $96, citing higher confidence in Intel's opportunity to help address industry constraints in leading edge wafers and packagingViaSatup 4% after announcing it was awarded a prime contract by the U.S. Space Force's Space Systems Command to build, launch and deliver the first of a proliferated fleet of small, maneuverable geosynchronous Earth orbit satellitesVoyager Technologiesup 3% after BTIG initiated coverage of shares with a Buy rating and $55 price targetEatonup 2% after announcing it will separate and combine its Mobility Group with Danain a Reverse Morris Trust transaction creating a combined company valued at over $10BUP AFTER EARNINGS -Navanup 20%Hooker Furnitureup 17%Lovesacup 1%Stitch Fixup 1%DOWN AFTER EARNINGS -Oxford Industriesdown 10%Oracledown 10%Aurora Cannabisdown 6%LOWER -Danadown 7% after announcing Eatonwill separate and combine its Mobility Group with the company in a Reverse Morris Trust transaction

Reports Q4 adjusted EBITDA $9.2M vs. $14.1M last year. "During FY26, we exceeded our projection for global medical cannabis net revenue1 led by double-digit growth in Europe and delivered on our expectation for Adjusted EBITDA with both at record outcomes. Our performance validates Aurora's global medical cannabis strategy which has positioned us as a leading provider in Canada, Europe, Australia, and New Zealand," said CEO Miguel Martin. "We believe Aurora's leadership in medical cannabis is built upon our regulatory expertise, extensive and recently expanded supply network of EU-GMP certified facilities, and proven commercial execution. We are confident that these attributes create a competitive advantage as we navigate the evolving industry dynamics to maintain and expand global market share, while driving international growth".

Roth Capital notes that the DOJ has officially rescheduled cannabis products that are FDA approved and products regulated by state medical programs to Schedule 3 and points out that an ALJ hearing has been scheduled on June 29 to assess broader rescheduling, including adult-use. Highlighting the language that "holders of state medical marijuana licenses will no longer be subject to the deduction disallowance imposed by Section 280E," the firm believes the final order is "extremely favorable for" go-forward 280E; retrospective 280E; the potential for imports/exports; ultimate adult-use rescheduling; and "sector investability." Publicly traded companies in the cannabis space include Aurora Cannabis (ACB), CV Sciences (CVSI), Canopy Growth (CGC), Cronos Group (CRON), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), IGC Pharma (IGC), Tilray (TLRY), Trees Corporation (CANN) and Trulieve Cannabis (TCNNF).

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly.MARIJUANA:In accordance with President Trump's December 18, Executive Order on Increasing Medical Marijuana and Cannabidiol Research, the Justice Department and the Drug Enforcement Administration announced the issuance of an order immediately placing both FDA-approved products containing marijuana and marijuana products regulated by a state medical marijuana license in Schedule III of the Controlled Substances Act, as well as the initiation of an expedited administrative hearing process to consider the broader rescheduling of marijuana from Schedule I to Schedule III. The new hearing, beginning June 29, 2026, will provide a timely and legally compliant pathway to evaluate broader changes to marijuana's status under federal law. Together, these actions provide immediate and long-term clarity to researchers, patients, and providers alike while still maintaining strict federal controls against illicit drug trafficking. Acting Attorney General Todd Blanche is placing both FDA-approved drug products containing marijuana, and medicinal marijuana products subject to a qualifying state-issued license in Schedule III under his authority to reschedule drugs to carry out the United States' obligations under the Single Convention on Narcotic Drugs. This action recognizes the longstanding regulation of medical marijuana by state governments and the need for a common-sense approach to this reality. "The Department of Justice is delivering on President Trump's promise to expand Americans' access to medical treatment options," said Acting Attorney General Todd Blanche. "This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information." Publicly traded companies in the space include Aurora Cannabis, CV Sciences, Canopy Growth, Cronos Group, Goodness Growth, Green Thumb Industries, IGC Pharma, Tilray, Trees Corporationand Trulieve Cannabis.STRAIT OF HORMUZ:In a post on Truth Social, President Trump stated, "I have ordered the United States Navy to shoot and kill any boat, small boats though they may be (Their naval ships are ALL, 159 of them, at the bottom of the sea!), that is putting mines in the waters of the Strait of Hormuz. There is to be no hesitation. Additionally, our mine "sweepers" are clearing the Strait right now. I am hereby ordering that activity to continue, but at a tripled up level! Thank you for your attention to this matter."SPIRIT AIRLINES:Members of President Donald Trump's team have vocalized differing views about the administration's plan to save Spirit Airlines,, Brian Schwartz of The Wall Street Journal, citing people familiar with the matter. Both Commerce Secretary Howard Lutnick and Transportation Secretary Sean Duffy gave their perspectives on the deal to the president. Lutnick argued this would be seen as a political win by coming to Spirit's rescue months before the midterm elections, people familiar with the matter said. Meanwhile, Duffy argued an agreement with Spirit could have negative political consequences, voicing skepticism about what the government is going to get out of having a stake in the business.